Device-Based Nonspecific Immunomodulation Therapy (Celacade), and Its Potential Role in the Treatment of Chronic Heart Failure-Reference-Cited by-同舟云学术

Device-Based Nonspecific Immunomodulation Therapy (Celacade), and Its Potential Role in the Treatment of Chronic Heart Failure

Published:2008-11 Issue:6 Volume:16 Page:280-287
ISSN:1061-5377
Container-title:Cardiology in Review
language:en
Short-container-title:

Author:

Sporter Robert J.,Kim Joon-Hyuk,Frishman William H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference51 articles.

1. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.;Hunt;Circulation,2005

2. The year in heart failure.;Tang;J Am Coll Cardiol,2007

3. Epidemiology, aetiology, and prognosis of heart failure.;McMurray;Heart,2000

4. Hyperkalemia, congestive heart failure, and aldosterone antagonism.;Sica;Congest Heart Fail,2003

5. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.;Noviasky;Pharmacotherapy,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of anti-inflammatory drugs and nanoparticle-based drug delivery models in the management of ischemia-induced heart failure;Biomedicine & Pharmacotherapy;2021-10

2. Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies;Therapeutics and Clinical Risk Management;2016-06

3. Heart failure: Novel therapeutic approaches;Journal of Postgraduate Medicine;2015

4. The irrationality of a non-specific immunomodulation therapy used in cardiovascular diseases deserves a critical comment;Atherosclerosis;2010-07

5. Current World Literature;Current Opinion in Supportive & Palliative Care;2009-12